Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Molluscum Contagiosum in the Pediatric Population: Expert Consensus Guidance on Prevention and Treatment.
Journal: Journal of drugs in dermatology : JDD
Published: August 05, 2026
Optimal Use Recommendations and Stewardship Principles with Oral Antibiotics in Acne Vulgaris Management: An Expert Consensus Panel.
Journal: The Journal of clinical and aesthetic dermatology
Published: February 05, 2026
SAIGE I: Staphylococcus aureus, Immunological, Genetic, and Environmental (SAIGE) Factors Contributing to Atopic Dermatitis and the Use of Ceramide-Containing Skincare.
Journal: Journal of drugs in dermatology : JDD
Published: October 02, 2025
The Atopic Dermatitis Continuum: An Updated Paradigm for a Common Disorder and a Novel Multipurpose Treatment Option.
Journal: Journal of drugs in dermatology : JDD
Published: September 05, 2025
SAIGE II: The Role of Staphylococcus aureus in Skin Barrier Dysfunction and the Development and Severity of Atopic Dermatitis in Young Children.
Journal: Journal of drugs in dermatology : JDD
Published: August 07, 2025
Efficacy and Safety of Lebrikizumab in Adult and Adolescent Patients with Skin of Color and Moderate-to-Severe Atopic Dermatitis: Results from the Phase IIIb, Open-Label ADmirable Study.
Journal: American journal of clinical dermatology
Published: July 06, 2025
INDIVIDUAL ARTICLE: Appraisal of Ruxolitinib 1.5% Cream as a First-Line Topical Therapeutic Agent for Adolescents and Adults With Mild-to-Moderate Atopic Dermatitis.
Journal: Journal of drugs in dermatology : JDD
Published: February 06, 2025
INDIVIDUAL ARTICLE: Ruxolitinib 1.5% Cream and the "Boxed Warning Paradox": Reappraisal of Safety Through the Lens of Pharmacokinetics.
Journal: Journal of drugs in dermatology : JDD
Published: February 06, 2025
Recommendations to Improve Outcomes in Acne and Acne Sequelae: A Focus on Trifarotene and Other Retinoids.
Journal: Dermatology and therapy
Published: October 11, 2024
Tapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trials.
Journal: Journal of the American Academy of Dermatology
Published: February 08, 2024
Diagnosis and Management of Pediatric Psoriasis: An Overview for Pediatricians.
Journal: Journal of drugs in dermatology : JDD
Published: August 09, 2023
Last Updated: 09/26/2026